Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics

Cancer Lett. 2023 Apr 10:559:216104. doi: 10.1016/j.canlet.2023.216104. Epub 2023 Mar 1.

Abstract

Hepatoid adenocarcinoma (HAC) is a rare, malignant, extrahepatic tumor with histologic features similar to those of hepatocellular carcinoma. HAC is most often associated with elevated alpha-fetoprotein (AFP). HAC can occur in multiple organs, including the stomach, esophagus, colon, pancreas, lungs, and ovaries. HAC differs greatly from typical adenocarcinoma in terms of its biological aggression, poor prognosis, and clinicopathological characteristics. However, the mechanisms underlying its development and invasive metastasis remain unclear. The purpose of this review was to summarize the clinicopathological features, molecular traits, and molecular mechanisms driving the malignant phenotype of HAC, in order to support the clinical diagnosis and treatment of HAC.

Keywords: Alpha-fetoprotein; Clinical feature; Histopathology; Malignant phenotype; Molecular characterization.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma* / drug therapy
  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / pathology
  • Stomach Neoplasms* / pathology
  • alpha-Fetoproteins

Substances

  • alpha-Fetoproteins